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Analysis of Interactions of Signaling Proteins with Phage-
Displayed Ligands by Fluorescence Correlation Spectroscopy
HELMI R. M. SCHLAMAN,1 KRISTIANE SCHMIDT,1,2 DORIEN OTTENHOF,3 MAARTEN H. VAN ES,3
TJERK H. OOSTERKAMP,3 and HERMAN P. SPAINK1
Fluorescent correlation spectroscopy (FCS) was used to measure binding affinities of ligands to ligates that are expressed by
phage-display technology. Using this method we have quantified the binding of the 14-3-3 signaling protein to artificial pep-
tide ligand. As a ligand we used the R18 artificial peptide expressed as a fusion in the cpIII coat protein that is present in 3
to 5 copies in an M13 phage. Comparisons of binding affinities were made with free R18 ligands using FCS. The result
showed a relatively high binding affinity for the phage-displayed R18 peptide compared with binding to free fluorescently
labeled R18. Quantification was supported by titration of the phage numbers using atomic force microscopy (AFM). AFM
was shown to accurately determine phage numbers in solution as a good alternative for electron microscopy. It was shown
to give reliable data that correlated perfectly with those of the viable phage numbers determined by classical bacterial infec-
tion studies. In conclusion, a very fast and sensitive method for the selection of new peptide ligands or ligates based on a
quantitative assay in solution has been developed. (Journal of Biomolecular Screening 2008:766-776)
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INTRODUCTION
TO ELUCIDATE THE INTERACTION BETWEEN SIGNALING PRO-TEINS and their target ligands is an increasingly important
research theme. Investigating these interactions is indispensable
to understand the underlying molecular mechanisms of signal
transduction pathways. Even more importantly, this research is
needed to reveal the factors that determine specificity in path-
ways involving a large number of proteins. Obviously, this may
be significant for the development of new therapeutics that bind
with high affinity to their signaling targets.
For most biological signal transduction pathways the lack
of quantitative data for binding affinity between all interac-
tion partners is a bottleneck for further understanding of the
underlying molecular mechanisms. This is especially limiting
to our understanding of factors that determine specificity in
pathways that involve a large number of proteins. A good
example is the 14-3-3 family of eukaryotic signaling proteins.
The 14-3-3 proteins function in all eukaryotic organisms as
dimeric proteins in a wide range of cellular processes, includ-
ing signaling, apoptosis, cell division, and patterning during
embryogenesis, by binding to many peptide ligands (for
reviews, see van Hemert et al.1 and Bunney et al.2). The mole-
cular function and specificity of the enormous amount of tar-
get ligands is unknown. Several isoforms of the protein have
been isolated in many species, for instance the human ζ-, τ-,
σ-, and β-isoforms, but their specific biological functions are
still hardly understood. There are indications that different
isoforms have specialized developmental functions because
they can display a tissue-specific distribution, for instance the
human σ-14-3-3 isoform occurs only in epithelial cells.3
Phage display is a very promising technique for the identifi-
cation of protein-protein interactions4-8 offering the possibility to
develop and to isolate new peptide ligands with desired binding
affinities. Therefore it is the most ideal method for the isolation
and characterization of ligands of 14-3-3 protein. During the 2
decades the technique has been in use, it has developed enor-
mously because of many applications and technical improve-
ments.9 The phage-display technology is based on expression of
foreign peptide or protein sequences as fusions to a phage capsid
protein presented on the surface of a phage particle. Phage dis-
play is a well-established method to isolate new ligands from a
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complex pool of sequences that bind to a known binding partner
(= ligate). The method offers the possibility of not only finding
the best binder to a known ligate, but in addition, identifying
alternative ligands. Because a physical link exists between the
binding characteristics (i.e., surface characteristics) and the
genetic information harbored by the phage, this is of great advan-
tage, for instance, for the construction of tailor-made ligands.
A large spectrum of methods is available to study the binding
affinity of an isolated ligand for its protein target, ranging from
radioactive detection assays, enzyme-linked immunosorbent assay
(ELISA), surface plasmon resonance (SPR) to microcalorimetry,
fluorescent polarization, time-resolved fluorescence resonance
energy transfer (TR-FRET), and fluorescence correlation spec-
troscopy (FCS). Nowadays, fluorescent techniques represent 1 of
the most important detection methods as an alternative to radioac-
tive assays because of their comparable sensitivity, safe handling,
long lifetime compared with often used radiolabels, environmental
friendliness, and because they are suitable for high-throughput
screening.10 A clear limitation, however is, that the fluorescent dye
coupled to 1 of the binding partners may cause practical problems
such as interference with binding affinity and/or ligand solubility
as discussed recently by de Keijzer et al.11 Methods as ELISA or
SPR12,13 do not struggle with this problem because they use no
labels. However, in these assays, the target is immobilized, which
limits these techniques strictly to in vitro studies. Moreover, the
anchoring of the target molecule onto a solid surface may perturb
the protein structure and its function.
Studies of binding in solution are enabled, for example, by
measuring fluorescent polarization, TR-FRET (for a review,
see Li et al.10) or FCS.14-16 FCS studies fluorescence fluctua-
tions caused by changes in number or orientation of single mol-
ecules diffusing in a tightly focused confocal detection volume
(~1 fL). An interaction between 2 different molecules (e.g.,
binding of a small fluorescently labeled molecule with a fast
diffusion time, due to its small size, to a larger ligand) results
in a change, meaning an increase, of the diffusion time. In addi-
tion, FCS also gives information on the absolute number of flu-
orescent molecules in the detection volume; that is, it can be
used to determine concentrations as well as the ratio of free and
bound molecules.
The advantages and limitations of FCS over other methods
have been discussed before (for instance, in Bahns et al.,14
Lagerkvist et al.,17 and Popeet al.18). In short, FCS offers a single-
step method in a homogenous solution in contrast to SPR, for
example, which is a multistep methods requiring washing steps;
no separation is required of bound and unbound fluorescent lig-
and and it operates at a single molecule level offering advantages
over ensemble measurements. Single molecule techniques can
also be considered as complementary to ensemble measurements
because they can discover properties that could not be predicted
on the basis of binding or diffusion characteristics predicted from
classical theory.11 Compared with other single molecule techniques,
FCS is less suited for detailed molecular analysis, but it is very
fast, it offers extremely high sensitivity and therefore requires
only small quantities, and, in principle, it gives the possibility to
measure affinity constants. FCS is therefore 1 of the most promi-
nent single molecule techniques for biological research.15,19
As proof of principle to establish whether phage display
combined with FCS is an accurate approach and has significant
advantages above other approaches to identify and characterize
new peptide ligands of signaling proteins, we have studied the
interaction between human and yeast 14-3-3 proteins and a pre-
viously identified peptide ligand called R18.20
The interaction between R18 and 14-3-3 protein was chosen as
a model for the following reasons: (1) Binding of R18 displayed
on the phage surface to 14-3-3 protein in solvent has been
shown.20 (2) R18 is bound as a nonphosphorylated ligand by τ-,
β-, and ζ-isoforms of 14-3-3 protein.20,21 (3) Isolated dimeric 14-
3-3 proteins labeled with fluorescent tags and proven to be func-
tional were available.3 (4) The molecular binding mechanism is
well known: the horseshoe-shaped, dimeric 14-3-3 protein has 2
equivalent binding sites 6.5 nm apart that act independently of
each other. (5) The core R18 amino acid sequence WLDLE is
bound by 14-3-3,21 and 2 flanking cystidine residues that are 14
amino acids apart from each other form an S-S bridge. As a result,
the bound sequence of the R18 peptide sequence “bulbs out” of
its flanking sequences, and these therefore will not interfere with
the fluorescent tag of the bound labeled 14-3-3 protein.
Previous work of Lagerkvist and others17 has pioneered the
use of FCS for analysis of phage-displaying monoclonal anti-
bodies against hepatitis C virus and the soluble antigen. In a
subsequent study, Bahns et al.14 used FCS to further character-
ize interactions between M13 phages and antibodies. However,
an application for the measurement of affinity constants for the
interaction of phage-displayed peptide ligands and signaling
proteins has not been reported yet.
In this work we show that the combination of phage display
with FCS may be applied as a powerful method for the quanti-
tative characterization of ligands binding to their partner ligate.
By comparison of binding studies of 14-3-3 protein with free
R18 peptide ligands, we show that the affinity of 14-3-3 protein
for the R18 peptide is strongly influenced by the presence of
additional surrounding peptide sequences.
MATERIALS AND METHODS
R18 peptide labeled with TAMRA
The R18 amino acid sequence NH2-PHCVPRDLSWLDLEAN-
MCLP-COOH labeled with tetramethylrhodamine (TAMRA) at
the N-terminus was synthesized by Sigma (Sigma-Genosys 
Ltd, Cambridge, UK). MS spectra showed no degradation of the
Schlaman et al.
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peptide. It was stored at –20 °C as lyophilized powder. The peptide,
designated as R18-TAMRA, was dissolved to 46 μM in 20 mM
HEPES pH 7.01, aliquoted, and stored in the dark at –20 °C.
Construction of R18 sequence in the phage-display vector
E. coli strain DH5α (Invitrogen Life Technologies, Paisley,
UK) was used for propagation and isolation of plasmids. All mol-
ecular handlings were performed according to standard methods.22
The clone GST-R18 in the vector pGEX-2T (Pharmacia,
Buckinghamshire, UK) was a kind gift of Dr. Fu (Emory Univer-
sity, Atlanta, GA). The DNA sequence of the R18 insert was deter-
mined by BaseClear (Leiden, The Netherlands) using primer
pGEX5′ (5′-GGGCTGGCAAGCCACGTTTGGTG-3′, synthe-
sized by BaseClear). Based on this sequence, the oligonucleotides
R18 sense (5′-catggccgacggggctcctcattgtgttccgagggatctgtcgtggctt-
gatctagaggcgaatatgtgtcttccgggggccgctggggc-3′, overlapping NcoI
site sequences and XbaI site in italics) and R18 antisense 
(5′-ggccgccccagcggcccccggaagacacatattcgcctctagatcaagccac-
gacagatccctcggaacacaatgaggagccccgtcggc-3′, overlapping NotI site
sequences and XbaI site in italics) were synthesized by Isogen
(Amsterdam, The Netherlands). The oligonucleotides were phos-
phorylated, annealed, and ligated into dephosphorylated vector
pHEN223 (a kind gift of Dr. Schots, Wageningen University)
digested with NcoI and NotI, yielding plasmid pMP2043.
Sequence determination of the independent clones pMP2043.1,
pMP2043.2, and pMP2043.19 revealed a sequence as expected for
R18 translationally fused to fd-geneIII.
Isolation of phages
E. coli strain TG124 was used for propagation of phages as it
has been reported to be superior to strain XL1-Blue in phage pro-
duction.25 Vectors pHEN2, pMP2043.2, and pMP2043.19 were
transformed into TG1 by standard methods.22 For phage produc-
tion, hyperphage M13K07ΔpIII (Progen Biotechnik, Heidelberg,
Germany) diluted in water until multiplicity of infection (m.o.i.)
of 1012 was used as helper phage. Essentially, the phage produc-
tion protocol described before24 was followed with modification
as described by Progen (Heidelberg, Germany) and adapted to
local conditions. In short, bacteria grown on Minimal Medium,22
were transferred to liquid 2x TY medium26 containing 1% glucose
and cultured for 16 h at 37 °C. Subsequently, the precultures were
100× diluted in 2x TY medium, grown at 37°C until mid-
log-growth phase, and subsequently infected by helper phage (20
phages/bacterium) for 60 min at 37 °C. Unattached helper phages
were removed by centrifugation. Bacterial pellets were suspended
in 2x TY medium supplemented with kanamycin (25 μg/mL) to
select for helper phages and phage production was allowed to take
place by growth at 30 °C for 16 h. All media were supplemented
with carbenicillin (100 μg/mL) if appropriate. Phages were iso-
lated from the growth medium by precipitation using PEG/NaCl
(20% polyethylene glycol 6000, 2.5 M NaCl) and suspended in
phosphate-buffered saline (PBS), pH 7.2 A 2nd precipitation of
phages was carried out using again PEG/NaCl and suspending
them in PBS, pH 7.2. Finally, the phage preparation was sterilized
by gentle passing over a 0.45-μm filter (Minisart NML, Sartorius,
Göttingen, Germany) and they were kept at +4 °C. 
The titer of the phage preparations was determined as
number of plaque-forming units (pfu)/mL by infecting TG1
cells with serial dilutions of phage preparations, and plating in
triplicate on TYE media (8 g of NaCl, 10 g of Tryptone, 5 g of
yeast extract) containing 1% glucose and supplemented with
carbenicillin (100 μg/mL) or kanamycin (50 μg/mL).
Recombinant 14-3-3 proteins
Recombinant human 14-3-3 σ-isoform proteins translation-
ally fused to cyan fluorescent protein (CFP) or to yellow fluo-
rescent protein (YFP; indicated as σ-14-3-3-CFP and
σ-14-3-3-YFP, respectively)3 were isolated from yeast as a
dimeric protein using gel filtration and provided by Dr. van
Hemert (Leiden University, The Netherlands) in 50% glycerol,
50 mM Tris-HCl pH 7.6, 300 mM NaCl, 1 mM DTT (37 and 5
μM solution, respectively), and stored at –20 °C. The yeast 14-
3-3 protein BMH2 was provided by Dr. van Hemert as 16 μM
solution in the same buffer and stored at –80 °C.
Theoretical concept of fluorescence correlation spectroscopy
FCS (for review, see Eigen and Rigler15) was used to analyze
the fluorescence intensity fluctuations originating from single
fluorescently labeled molecules diffusing in a confocal detec-
tion volume of less than 0.5 fL. The dependence of diffusion
time on beam size and molecular weight of the diffusing com-
ponents are addressed by Saxton.27 Correlation of the intensity
fluctuations over time yields the so-called autocorrelation func-
tion, G(t). Using a 1-component model the experimental auto-
correlation curves were fitted by:
G(t) =
where N denotes the number of fluorescent particles in the
detection volume, T the fraction of fluorophores decaying
through the triplet state, τt the triplet lifetime, τdiff the diffu-
sion time, and SP the structural parameter describing the
confocal volume. The triplet state of the fluorophore indi-
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For 2 components, the 1-component model was extended to:
G(t) = 1 +
where y denotes the relative fraction of the 1st component, τ1
the diffusion time of the 1st component, and τ2 the diffusion
time of the 2nd component. The ratio between the 2 compo-
nents (e.g., free and bound dye) can be directly obtained from
fitting the measured autocorrelation curves.
FCS measurements
FCS measurements were performed on a ConfoCor2 (Zeiss,
Jena, Germany) using the 514-nm for YFP and 543-nm laser lines
for TAMRA excitation, respectively. The fluorescence emission
was passed through a 530- to 560-nm band pass (for detection of
σ-14-3-3-YFP) or a 585-nm low-pass filter (for detection of R18-
TAMRA) and detected using an avalanche photodiode. The sig-
nals were software correlated to obtain the autocorrelation
functions. Calibration measurements with standard dyes (TAMRA
and Rhodamine6G) were performed to determine the geometry
and the size of the detection volumes before each series of mea-
surements. Typically volumes of 0.170 and 0.155 fL were found
for TAMRA and Rhodamine6G, respectively.
One volume of 10 to 50 nM R18-TAMRA diluted in bind-
ing buffer (20 mM HEPES pH 7.0, 150 mM KCl, 0.005%
Tween-20) was mixed with an equal volume of 100 to 1000 nM
σ-14-3-3-CFP or -BMH2 on ice for 15 min. Next, 10 μL of the
mixture was transferred to an 8-well glass-bottom chamber
(Nunc GmbH, Wiesbaden, Germany) and measurements were
performed immediately. The presence of Tween-20 in the bind-
ing buffer was essential to prevent background binding of the
TAMRA label to the glass surface.
Phages were diluted from stock solutions containing 5–10 ⋅
1012 pfu/mL just before use in freshly prepared binding buffer.
One volume of diluted phages was mixed with an equal volume
of 10 nM σ-14-3-3-YFP. The 14-3-3 protein was allowed to
bind to the phages for 15 to 20 min on ice, and subsequently 10
μL of the mixture was transferred to an 8-well glass-bottom
chamber (Nunc GmbH). Measurements were performed imme-
diately afterward.
For each autocorrelation curve, 5 individual measurements
(30 sec each) were averaged. The ConfoCor2 software was
used for fitting autocorrelation curves. When fitting curves with
2 or more components, the values of the diffusion times for the
faster components were fixed, using the values that were deter-
mined in earlier experiments with only 1 component present in
the solution. Likewise, for determination of binding kinetics,
the values of the different components were kept fixed to fit the
ratio of the different components.
Atomic force microscopy
Tapping mode atomic force microscopy (AFM) was done in
air at room temperature using a Nanoscope IIIa (Veeco, Santa
Barbara, CA). Phages were diluted in HPLC-grade H2O using
pipette tips of Sarstedt (product number 70.760); 2 μL of
diluted phage solutions was deposited on freshly cleaved mica.
The sample droplet spread over an area of 15 mm2 and was
dried under a gentle flow of dry nitrogen. Sixteen squares each
of 36 μm2 were imaged on various places of the sample.
RESULTS
Construction and production of R18-displaying phages
To display the R18 peptide on the outside of a phage, the
phagemid vector pHEN2 was chosen because it is easy to han-
dle during molecular manipulations because of its high copy
number (e.g., cloning, nucleotide sequencing), the expression
of the insert can be regulated because of the presence of the lac
promoter upstream of the insert, and the fusion is made with the
phage fd minor coat protein III (cpIII). This protein, located at
only 1 proximal end of the phage, is absolutely required for
infection of an E. coli host, but, surprisingly, it tolerates inser-
tions (for a review, see Hoogenboom et al.28) probably because
of the fact that it sticks out of the phage envelope. The transla-
tional fusion of the R18 sequence fused to the 5′ end of 
fd-geneIII resulted in vector pMP2043. Several independent
clones with the correct nucleotide sequence were obtained des-
ignated pMP2043.1, pMP2043.2, and pMP2043.19.
Helper phages are required for the isolation of phages from
phagemids. However, a drawback of this system is that rela-
tively large quantities of phages with wild-type cpIII are iso-
lated in addition to phages with recombinant cpIII. Therefore,
use was made of the helper phage M13K07ΔpIII, lacking the
genetic information for cpIII,29 because we did not have a
selection method for phages displaying the R18 peptide readily
available. In this way, theoretically, all phages produced will
have a recombinant cpIII.
Phages were produced from bacterial strains containing
phagemid pMP2043.2, pMP2043.19, or pHEN2. As control, the
same isolation procedure was applied to a bacterial strain lacking
a phagemid (indicated as “TG1”). The titer of the phage prepara-
tions was determined on carbenicillin-containing media. For
unknown reasons, the titer of pMP2043-containing phages was
found repeatedly to be 10 to 25 times higher (3.9–
8 ⋅ 1012 pfu/mL) than that of pHEN2-containing phages (0.3 ⋅ 1012
pfu/mL). On kanamycin-containing media, phages could have
propagated that contain the genetic information from the helper
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phage. Titers found on these media were in the order of 108
pfu/mL and equal for all preparations. These results show that
almost all phages that were isolated from pMP2043-containing
bacteria contain the genetic content of the R18-geneIII fusion.
FCS measurements of binding of R18 peptide 
to 14-3-3 protein
The σ-isoform of human 14-3-3 protein was used as ligate
in binding studies with phages displaying R18 on their surface.
First, binding between σ-14-3-3 and free R18 peptide was ana-
lyzed to establish whether detection of binding of R18 by the
14-3-3 protein using FCS was feasible. Furthermore, the exper-
imental conditions were optimized using this system. In the
binding experiments, ligates were fused to autofluorescent pro-
teins CFP and YFP because in forthcoming biological experi-
ments fluorescently labeled protein had to be used (see below).
YFP or CFP fluorescent tags do not interfere with ligand inter-
action,3 but they cause a substantial increase in molecular
weight of the protein (the expected molecular weight of
monomeric 14-3-3 protein without and with the autofluores-
cent protein is 27 and 57 kDa, respectively) and therefore will
influence the observed diffusion time.
In FCS, the ligand, usually the smallest molecule, is fluo-
rescently labeled, and its fate is followed during the interaction
with its binding partner or ligate, usually the largest molecule.
To this end, TAMRA-labeled R18 peptide was allowed to bind
to dimeric σ-14-3-3 protein labeled with CFP (indicated as σ-
14-3-3-CFP)3. To detect the interaction, the dye TAMRA was
chosen to label the ligand because it is known as a suitable dye
for FCS, and its emission does not overlap with that of CFP
(λemission 480 nm). No background signal could be detected from
the CFP tag when a 585-nm low-pass filter was used to cut off
the CFP emission (Table 1). Test measurements with a series of
KCl concentrations in the binding buffer (50, 100, 150, 250,
and 500 mM) showed that the specificity of the binding was
increased by the addition of KCl with an optimum at 150 mM
(data not shown). Addition or omission of DTT to the binding
buffer had no detectable effect and was therefore omitted.
MgCl2, an important molecule described for functioning of 14-
3-3 protein, showed no effect on the binding and was therefore
also omitted from the binding buffer. Reproducible results were
obtained by using 5 nM R18-TAMRA and 100 nM σ-14-3-3-
CFP in the binding experiments and when binding was allowed
to take place for 15 to 20 min on ice or at ambient temperature,
apparently, after this time equilibrium was established.
The TAMRA dye could be detected specifically in the
experimental settings established with a diffusion time of 24
μs. Free TAMRA-labeled R18 peptide showed a diffusion time
of 50 μs, without a significant amount of free dye. For binding
of the TAMRA-labeled R18 peptide to the 14-3-3 protein
BMH2, without a fluorescent tag, a diffusion time of 178 μs
was obtained (Table 1). The binding of TAMRA-labeled R18
peptide to 14-3-3 proteins was specific as shown by the control
experiment in which BSA was used. In this experiment no
binding of R18 was observed, that is, no increase of the diffu-
sion time (Table 1).
The diffusion time of TAMRA-labeled R18 peptide
increased to 215 μs when σ-14-3-3-CFP protein was added
(Table 1). Figure 1 depicts 2 typical FCS measurements for
free TAMRA-labeled R18 and binding to the σ-14-3-3-CFP
protein.
FCS was also used to determine the binding constant of
TAMRA-labeled R18 peptide to σ-14-3-3-CFP. For this pur-
pose, the concentration of σ-14-3-3-CFP was varied between 5
and 1000 nM and the ratio of bound and free R18-TAMRA was
determined from fitting the measured autocorrelation curves
(Fig. 2, circles). For estimating the binding constant the data
were fitted with the assumption of a 1-site binding component
model (Fig. 2, line), yielding a value of 69 nM ± 22 pM. 
FCS measurements of binding of R18 displayed on phage
surface to 14-3-3 protein
A 1st set of experiments, in which the experimental settings for
the measurement of binding of 14-3-3 protein by R18-displaying
Table 1. Binding of Fluorescently Labeled R18 Peptide to σ-14-3-3 Fused to Autofluorescent 
Protein CFP Determined by FCS with Detection at 530–560 nm
Ligand (Fluorescently 
Labeled) Ligate τ1a (μs) τ2a (μs) Fraction2 (%) τ3a (μs) Fraction3 (%) Binding Constant
— σ-14-3-3-CFP N.D. — — — —
Dye TAMRA — 24 ± 2 — — — —
R18-TAMRA — N.D. 50 ± 2 100 — —
R18-TAMRA σ-14-3-3-CFP — 50 48 215 ± 14 52 69 nM ± 22 pM
R18-TAMRA BMH2 — 50 44 178 ± 7 56 —
R18-TAMRA BSA — 50 >99 260 <1 —
CFP, cyan fluorescent protein; FCS, fluorescence correlation spectroscopy; N.D., not detectable; TAMRA, tetramethylrhodamine. 
a. τ1–3 are component diffusion times. Data are the mean of 5–10 independent experiments each performed in 5-fold. 
phages using FCS was tested, showed a high amount of back-
ground fluorescence probably due to growth media residues that
have been precipitated together with the phages. This background
fluorescence was also observed in a control sample that was
obtained by using an identical isolation procedure for cultures of
E. coli TG1 cells lacking a phagemid, as for the isolation of phages
(data not shown). Therefore a 2nd precipitation of the phage prepa-
ration was performed. No decrease in the titers was observed (data
not shown), and, just as important, after this additional purification
step no background fluorescence was observed in the FCS mea-
surements anymore.
Binding of σ-14-3-3 fused to YFP (indicated as σ-14-3-3-YFP)
to R18-displaying phages was assessed using the binding condi-
tions set before with σ-14-3-3-CFP and R18 peptide except that
the fluorescent dye (YFP) was excited with a 514-nm laser line
and a 530- to 560-nm band pass filter was used to follow the fate
of the σ-14-3-3-YFP ligand. In these former experiments, 5 nM
R18-TAMRA (equal to 3 · 1012 molecules/mL) in reaction with
100 nM σ-14-3-3-CFP (equal to 6 · 1013 molecules/mL) gave
reproducible results, meaning a 20-fold excess of ligate.
When no ligate was added to the 14-3-3-YFP-labeled pro-
tein, a diffusion time of 141 μs was observed (Table 2 and
Fig. 3, dotted line). An additional component with a diffusion
time of ~2000 μs appeared when phages isolated from cultures
with pMP2043-containing bacteria (indicated as phage 2043)
were added (Table 2 and Fig. 3, solid line) indicating that bind-
ing occurred. Two independently-obtained phage isolates
derived from 2 different clones (pMP2043.2 and pMP2043.19)
showed indistinguishable results (Table 2). In contrast, phages
isolated from control cultures with pHEN2-containing bacteria
(indicated as phage-pHEN2) showed a diffusion time similar to
samples when no ligate was added to the 14-3-3-YFP–labeled
protein (152 μs) indicating that no binding occurred (Table 2
and Fig. 3, dashed line). These results show clearly that specific
binding of R18-displaying phages by its ligate 14-3-3 protein
can be determined by FCS.
Subsequently FCS was used to determine the binding constant
for binding of σ-14-3-3-YFP to the phages displaying the R18
peptide. Figure 4 shows the ratio of free and bound σ-
14-3-3-YFP for binding to phage 2043.2 and phage 2043.19. The
minor coat protein cpIII contains 3 to 5 copies per phage at 1
proximal end of the phage. For calculations we assumed binding
of 1 molecule dimeric 14-3-3 protein to 1 phage according to con-
ventional 1st order kinetics. Binding of more 14-3-3 copies can-
not be excluded but is unlikely because of steric hindrance. We
have not found any indications of binding of multiple 14-3-3 pro-
teins to 1 phage as could be indicated by better fitting with other
settings based on multiple binding partners or by spikes in the
correlation curves. Based upon this assumption, we found KD:
1.6 · 107 phages/μL, which corresponds to about 30 pM.
Analysis of phage preparations by AFM
The most striking observation that was made in the FCS
studies was a 2000-fold difference in binding constant of free
R18 peptide with the ligate σ-14-3-3 protein compared with
R18 fused to fd-cpIII. In this latter case, the R18 peptide is
imbedded in a protein structure on the surface of the phage
suggesting that the neighborhood of the peptide influences its
binding characteristics. Alternatively, the huge difference in bind-
ing constant could be explained by supposing that more bind-
ing sites for 14-3-3 are present in the phage preparations than
expected. Our studies thus far were based on the assumption
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FIG. 1. Normalized fluorescence correlation spectroscopy (FCS)
autocorrelation curves for free tetramethylrhodamine (TAMRA)-
labeled R18 peptide (dashed line) and TAMRA-labeled R18 peptide
after incubation with σ-14-3-3-CFP (solid line). The graph depicts the
time dependence of the autocorrelation function, G(t). Both experi-
mental traces are the average of 5 individual measurements.
FIG. 2. Binding curve for binding of tetramethylrhodamine (TAMRA)-
labeled R18 peptide to σ-14-3-3-CFP (black circles). Each data point was
obtained as the average from fits of 3 autocorrelation curves. The line rep-
resents a fit to the data based on a 1-site binding model.
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that 3 to 5 R18 copies per phage particle are present and that all
R18 binding sites are present on viable phages.
To obtain further support for the estimated number and the
integrity of phages present in the preparations we performed visu-
alizations studies. In this way it was possible to determine
whether smaller fragments (representing broken phage particles)
were present in the phage preparation. Such fragments may con-
tribute to binding to 14-3-3 protein as observed with FCS, but
they are not viable and will therefore not show up as pfu. In a 1st
approach using transmission electron microscopy (TEM) studies
we were unable to characterize the average size of the phage par-
ticles in a reproducible way (data not shown). As an alternative,
AFM was used to measure a large representative number of phage
particles of 1 of the preparations used in FCS. Samples of phage
2043.2 were prepared on mica plates as a very thin outspread
layer and imaged according to the scheme in Figure 5A. In this
approach 4 squares of 36 μm2 were imaged on various places of
the sample (Fig. 5A). The experiment was repeated 3 times, each
time with freshly prepared dilutions of the phage preparation. The
images revealed that the phage particles were evenly distributed
over the sample and no indication for the presence of aggregates
was observed (Fig. 5B). In a typical experiment, the average
number of phages per 6 × 6 μm2 was 26 ± 6 for a 1000-fold 
dilution. Given the size of 15 mm2 for a 2 μL droplet, a concen-
tration of 5 ± 2 ⋅ 106 phages/μL could be derived in this sample.
For 1 of the images, the lengths of the phages were deter-
mined. The length varied between 480 nm and 1320 nm with a
median of 660 nm. In conclusion, no significant number of
small phage particles was observed that might represent a large
nonviable number of phages.
FIG. 3. Normalized FCS autocorrelation curves for free σ-14-3-3-
YFP (dotted line), after incubation with phage pHEN2 (negative control,
dashed line) and after incubation with phage 2043.2 (solid line). The
graph depicts the time dependence of the autocorrelation function, G(t).
Each experimental trace is the average of 5 individual measurements.
FIG. 4. Binding curve for binding of σ-14-3-3-YFP to phage 2043.2
(black circles) and phage 2043.19 (open circles). Each data point was
obtained as the average from fits of 3 autocorrelation curves. The
dashed line represents a fit to the data based on a 1-site binding model.
Table 2. Binding of Phages Displaying R18 Peptide on cpIII to Fluorescently 
Labeled σ-14-3-3-YFP Determined by FCS with Detection at >585 nm
Ligand (Fluorescently Labeled) Ligate τ1a (μs) τ2a (μs) Fraction2 (%) Binding Constantb
σ-14-3-3-YFP — 141 ± 13 — —
σ-14-3-3-YFP Phage 2043.2 141 1949 ± 162 58 ± 3 33 pM +/− 12 pM
σ-14-3-3-YFP Phage 2043.19 141 2619 ± 587 62 ± 4
σ-14-3-3-YFP Phage pHEN2 152 μs ± 24 N.D. N.D.
cpIII, coat protein III; FCS, fluorescence correlation spectroscopy; N.D. not detectable.
a. τ1-2 are component diffusion times. Data are the mean of 5-10 independent experiments each performed in 5-fold.
b. Binding constants for phages are based on pooled data from 4 independent measurement series. For each phage concentration, the amount of binding was fitted from 3 indepen-
dent experiments, each performed in 5-fold.
DISCUSSION
FCS offers the possibility to study the interaction of proteins
with other molecules qualitatively and quantitatively in solu-
tion. The aim of this study was to show that phage display in
combination with FCS is a very promising method for identi-
fying new peptide ligands and characterizing the binding. For
this purpose we investigated peptide ligands of the eukaryotic
signaling protein 14-3-3 displayed by phage M13. To our
knowledge, this is one of the very few reports studying a
recombinant filamentous phage with FCS. Former work
showed that it is possible to detect protein binding to phages
with FCS. These studies employed M13 phages and labeled
antibody against M13, antibody-displaying M13, or recombi-
nant T7, the latter being an icosahedral-shaped phage.17
As proof of principle, the R18 peptide, a known ligand of 
14-3-3 proteins,20 was displayed on the surface of the recombinant
M13 phage 2043 as a fusion with the minor coat protein cpIII. This
approach was successful, as shown by the binding experiments
analyzed using FCS. The recombinant phages bound specifically
to 14-3-3 protein and the binding constant could be determined
(Table 2 and Fig. 4). Binding between the phages and dimeric 
14-3-3 protein followed conventional 1st order kinetics up to 
a concentration of about 2 · 108 phages/μL (corresponding to 
~0.3 nM). In contrast to a previous report,17 no phage aggregates
interfered with our measurements because of the use of low phage
concentrations, avoiding shear forces when mixing the phage sam-
ples (no vortexing), short incubation times with the ligand, and the
presence of a detergent, Tween-20, in the binding buffer.
The diffusion time of the fluorescently labeled 14-3-3 pro-
tein (σ-14-3-3-YFP) increased more than 10-fold when the
R18-displaying phage was bound. From the diffusion time of
~2 ms (Table 2) fitted from our data we calculate a diffusion
constant of ~3.2 · 10–12 m2/sec. This value is considerably
smaller than the diffusion constants of ~1–2 · 10–11 m2/sec cal-
culated from the FCS data of Lagerkvist et al.17 and Bahns et
al.14 For this reason we also calculated the theoretical diffusion
constant for a rod.30 Assuming a length of 660 nm (as deter-
mined from the AFM images) and a diameter of 8 nm, we
arrived at a diffusion constant of 3.51 · 10–12 m2/sec, which
matches surprisingly well with our measured value. In this con-
text it is worth noting that our diffusion times were fitted from
experimental traces where about 60% of the labeled ligand was
bound by phages, whereas in the former studies less than 30%
of the fluorophores were bound to phage particles.
The recombinant phages 2043, harboring the R18 peptide
sequence fused to the 5′ end of the fd-geneIII, were produced
using M13 helper phages lacking the wild-type coat protein
geneIII. Because phage display is based on the physical link
between surface characteristics and genetic content of the
phage, and because viable phages were produced, it was
assumed that all phages would display the R18 peptide. A pos-
itive binding assay was not readily available nor was an alter-
native method to establish the R18-cpIII fusion at the protein
level. Western blotting using cpIII antibodies to determine
whether the fusion of R18 to cpIII was successful was not con-
sidered because cpIII migrates with an apparent molecular size
of 66 kDa in protein gels,31,32 and this size will not be altered by
the R18 peptide having a predicted size of ~2 kDa. Moreover,
antibodies to R18 were not available.
The TAMRA-labeled R18 peptide was successfully used to
test the feasibility that the interaction of the 14-3-3 protein with
its ligand could be measured in solution using FCS. Our data
show (Table 1) that the R18 peptide binds specifically to the
yeast 14-3-3 protein BMH2 and to the human σ-isoform of
dimeric 14-3-3 protein, each with different diffusion times as
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FIG. 5. (A) Scheme of the sample areas scanned by atomic force
microscopy (AFM). (B) One of the 16 AFM images used to determine
the density of viruses on the mica surface.
A
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expected. Binding of R18 peptide to these 2 isoforms of 14-3-
3 has not been shown before. However, our result is not so sur-
prising, because binding of R18 peptide to several isoforms of
14-3-3 protein has been shown before.20,21 It has been suggested
that R18 peptide probably binds to a common motif in the bind-
ing site of all 14-3-3 protein isoforms. The binding of R18 to
the dimeric protein σ-14-3-3-CFP followed a conventional 1st
order kinetic (Fig. 2), indicating that the protein acts as a
monovalent molecule, yielding a binding constant of 69 nM ±
22 pM. This number is very similar to the value of 70 to 90 nM
as published for R18 peptide using a radio affinity chromatog-
raphy binding assay and ζ-14-3-3 protein.20 Theoretically, the
very short distance of the 2 TAMRA-labeled R18 peptides
bound by 14-3-3, estimated as 6.5 nm,33 may contribute to
quenching of the fluorescent dye. However, no quenching,
instability, degradation, or release of the dye from the peptide
was observed.
A rather unexpected result was the observation that 14-3-3
protein binds the R18 peptide ligand with a higher binding coef-
ficient when it is imbedded in a protein context, as it is in the
recombinant phage, than when it occurs as free peptide. The
binding constant of free R18 peptide and R18 displayed by the
phage was 69 nM ± 22 pM and 33 ± 12 pM, respectively (Tables
1 and 2). Visual inspection of our phage preparations using AFM
indicated that this difference was not because there was a large
number of binding sites present in our phage preparations in
addition to viable phages. Rather, this result suggests that 2 R18
sequences displayed on the same phage particle may bind to one
14-3-3 protein resulting in a lower KD. This might be of relevance
to our understanding of how ligand binding to 14-3-3 protein
may contribute to different effects in vivo. This is of even greater
importance, because 14-3-3 is involved in a very wide range of
cellular processes by binding to very many different ligands (for
reviews, see Bunney et al.2 and van Hemert et al.34).
Visual analysis using AFM provided essential data on the
quality of our phage preparations. AFM imaging showed an
even distribution of phages with no aggregates and most, if not
all, phage particles were intact with an average length of 660
nm (Fig. 5B). This size is smaller than the published length of
M13 phages (~800 nm) but might be explained by the fact that
the length of the phage particle is determined by its genome
size and our phage particles contain the recombinant phagemid
pMP2043 whose size is smaller than that of M13 (~4.7 and
~6.4 kb, respectively). The lack of aggregates, which is
essential for binding studies, is likely due to the relative low
phage concentration in our preparations as has been reported
before.17 The concentration of phages determined by counting
in AFM images was in agreement with the expected number of
phages as established by pfu determination indicating that titer
determination is a reliable method to predict the number of
binding sites present in a phage preparation. 
A major concern when using AFM for particle counting was
that particles in the solution tend to accumulate at the edges of
the drying droplet and that they are not evenly distributed over
the sample. We could overcome this drawback by using very
small volumes of phage preparations and spreading it out over
a large area, using the purest water available and a quick dry-
ing method. Imaging of various dilutions of phage preparations
turned out to be crucial to find the most optimal experimental
setup. TEM or scanning electron microscopy is usually used to
analyze phage preparations (e.g., Bahns et al.14), but we found
AFM superior to TEM because of its higher sensitivity, low
background, and good reproducibility.
In our combined study of phage display and FCS, use was
made of fluorescently labeled 14-3-3 protein. The label was due
to a C-terminal translational fusion with the autofluorescent pro-
tein YFP. In the past decade, many reports have shown the enor-
mous potential of translational fusions with autofluorescent
proteins in cellular biological research.35 Recently, their use was
extended to FCS studies including those in living cells.36-38 The
main advantage of autofluorescently labeled proteins over the
use of proteins, to which the fluorescent dye is coupled chemi-
cally as usually done for FCS, is 2-fold. (1) The link of the flu-
orescent dye to the protein is made at the DNA level; therefore
the fluorophore is stably coupled to the protein and there is no
free fluorophore. (2) The function of the recombinant protein
carrying the autofluorescent protein can be established both in
vivo and in vitro prior to the FCS experiments. In this way,
potential problems as reported for fluorescently labeled biomol-
ecules with regard to binding affinity can be excluded. Indeed,
no indication of instability of the 14-3-3-YFP protein was
obtained. Additionally, bleaching, a well-known disadvantage
of autofluorescent proteins, was not detected because the expo-
sure time to the laser beam in FCS measurements is very short.
Furthermore, we conclude that 1 molecule of dimeric 14-3-3
protein binds to 1 phage displaying the R18 peptide in 3 to 5
copies. This conclusion is based on the fact that no abundant
spiking was observed during the FCS measurements and a bind-
ing curve for 1st order kinetic was satisfactory to fit our experi-
mental binding data.
In summary, we have developed a very fast and sensitive
method for quantitative measurement of ligate binding to phage-
displayed ligands. In conventional methods employed for phage
display, new ligands are isolated in a repeated cyclic process 
of large-scale phage production and recovery of potential 
ligands via affinity columns of binding partners, a method
known as biopanning (for a review, see, e.g., Hoogenboom39).
Characterization of the binding partners often makes use of
ELISA or an alternative biochemical assay both of which usually
exclude the determination on binding constants. The whole pro-
cedure of biopanning is laborious, very time consuming, and
characterized by many pitfalls. Our data show that FCS offers an
excellent alternative and less elaborate method for the isolation
and characterization of new ligands. It should be noted, however,
that FCS requires complex instrumentation and data process-
ing,18 which will limit general application. In contrast, for
instance, SPR measurements in biomolecular interactions are
more commonly used and they offer a wide variety of essays.13
Recently, interesting new applications of SPR measurements for
phage-displayed peptides have been shown by the development
of a bifunctional ligand display system.40 It would be of great
interest for future research to make comparisons of binding
affinities of phage-displayed ligands determined with FCS and
SPR methods using the same targets.
The results described in this article are promising with
regard to future possibilities of FCS that include its use for
high-throughput screening of large libraries of molecules for
the presence of individual molecules that possess improved or
more specific binding characteristics for signaling proteins
such as 14-3-3. Such libraries may arise from ligand evolution.
The combination of phage display, which enables the evolution
of peptide sequences, and FCS is a powerful method for quan-
titative characterization. However, to be able to select individ-
ual molecules from very large phage libraries based on
quantitative criteria, new technological developments are still
needed to increase the throughput and selection criteria, for
instance, using microfluidic sorting technology.
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